RecruitingPhase 3NCT07152639

Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

Studying Tuberculosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chengdu CoenBiotech Co., Ltd
Intervention
5μg/ml EEC(biological)
Enrollment
1784 enrolled
Eligibility
3 years · All sexes
Timeline
20252026

Study locations (8)

Collaborators

Beijing Chest Hospital, Capital Medical University · Wuhan Pulmonary Hospital · Changsha Central Hospital · The First Affiliated Hospital of Xinxiang Medical College · LiuZhou People's Hospital · Wuhan Central Hospital · Yichang Central People's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07152639 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis

← Back to all trials